We have recorded numerous media reports about the intent of the German Contergan Foundation to cease payments to people affected by "Sedalis". Grünenthal's position on this matter is as follows:
The responsible bodies of the Contergan Foundation decided almost fifty years ago that "Sedalis" is a product that is captured by the Contergan Foundation Law. We see no reason to doubt this assessment. Whilst we disagree with the intent of the Contergan Foundation, we have no influence on it nor were we informed about this intent in advance.
Head Global Communications
Phone +49 241 569-1335